Prediction of P-glycoprotein inhibitors with machine learning classification models and 3D-RISM-KH theory based solvation energy descriptors

被引:8
作者
Hinge, Vijaya Kumar [1 ]
Roy, Dipankar [1 ]
Kovalenko, Andriy [1 ,2 ]
机构
[1] Univ Alberta, Donadeo Innovat Ctr Engn 10 203, Dept Mech Engn, 9211-116 St NW, Edmonton, AB T6G 1H9, Canada
[2] Nanotechnol Res Ctr, 11421 Saskatchewan Dr, Edmonton, AB T6G 2M9, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
P-glycoprotein (PgP); PgP inhibitors; Multidrug resistance (MDR); 3D-RISM-KH; Solvation free energy; Excess chemical potential; Partial molar volume (PMV); IN-SILICO MODELS; MULTIDRUG-RESISTANCE; MDR MODULATORS; REVERSAL; QSAR; GENE; TRANSPORTERS; ACTIVATION; EXPRESSION; FLAVONOIDS;
D O I
10.1007/s10822-019-00253-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Development of novel in silico methods for questing novel PgP inhibitors is crucial for the reversal of multi-drug resistance in cancer therapy. Here, we report machine learning based binary classification schemes to identify the PgP inhibitors from non-inhibitors using molecular solvation theory with excellent accuracy and precision. The excess chemical potential and partial molar volume in various solvents are calculated for PgP +/- (PgP inhibitors and non-inhibitors) compounds with the statistical-mechanical based three-dimensional reference interaction site model with the Kovalenko-Hirata closure approximation (3D-RISM-KH molecular theory of solvation). The statistical importance analysis of descriptors identified the 3D-RISM-KH based descriptors as top molecular descriptors for classification. Among the constructed classification models, the support vector machine predicted the test set of Pgp +/- compounds with highest accuracy and precision of similar to 97% for test set. The validation of models confirms the robustness of state-of-the-art molecular solvation theory based descriptors in identification of the Pgp +/- compounds.
引用
收藏
页码:965 / 971
页数:7
相关论文
共 62 条
[1]   P-glycoprotein Inhibition for Optimal Drug Delivery [J].
Amin, Md. Lutful .
DRUG TARGET INSIGHTS, 2013, 7 :27-34
[2]  
[Anonymous], CONVERT STAT ANAL OB
[3]  
[Anonymous], 2018, MOL OP ENV MOE
[4]   DECREASED MUTATION-RATE FOR CELLULAR-RESISTANCE TO DOXORUBICIN AND SUPPRESSION OF MDR1 GENE ACTIVATION BY THE CYCLOSPORINE PSC-833 [J].
BEKETICORESKOVIC, L ;
DURAN, GE ;
CHEN, G ;
DUMONTET, C ;
SIKIC, BI .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (21) :1593-1602
[5]   Random forests [J].
Breiman, L .
MACHINE LEARNING, 2001, 45 (01) :5-32
[6]   A Novel Approach for Predicting P-Glycoprotein (ABCB1) Inhibition Using Molecular Interaction Fields [J].
Broccatelli, Fabio ;
Carosati, Emanuele ;
Neri, Annalisa ;
Frosini, Maria ;
Goracci, Laura ;
Oprea, Tudor I. ;
Cruciani, Gabriele .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (06) :1740-1751
[7]   QSAR Models for P-Glycoprotein Transport Based on a Highly Consistent Data Set [J].
Broccatelli, Pablo .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2012, 52 (09) :2462-2470
[8]  
Case D., AMBER
[9]   INTERNAL DUPLICATION AND HOMOLOGY WITH BACTERIAL TRANSPORT PROTEINS IN THE MDR1 (P-GLYCOPROTEIN) GENE FROM MULTIDRUG-RESISTANT HUMAN-CELLS [J].
CHEN, CJ ;
CHIN, JE ;
UEDA, K ;
CLARK, DP ;
PASTAN, I ;
GOTTESMAN, MM ;
RONINSON, IB .
CELL, 1986, 47 (03) :381-389
[10]   ADME Evaluation in Drug Discovery. 10. Predictions of P-Glycoprotein Inhibitors Using Recursive Partitioning and Naive Bayesian Classification Techniques [J].
Chen, Lei ;
Li, Youyong ;
Zhao, Qing ;
Peng, Hui ;
Hou, Tingjun .
MOLECULAR PHARMACEUTICS, 2011, 8 (03) :889-900